Evidence map›Paper›PMID 38000027›Full record

ArticleScience advances2023

Partial in vivo reprogramming enables injury-free intestinal regeneration via autonomous

Jumee Kim, Somi Kim, Seung-Yeon Lee, Beom-Ki Jo, Ji-Young Oh, Eun-Ji Kwon, Keun-Tae Kim, Anish Ashok Adpaikar, Eun-Jung Kim, Han-Sung Jung and 6 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Gelsolin's Protective Role in MASH through F-Actin Regulation and P53 Degradation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Mammalian Blastema: Possibility and Potentials.International journal of stem cells · 2025
    Review
  13. Review
  14. Research ofRegenerative therapy · 2025
    Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Jumee KimCollege of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Somi KimDepartment of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.ORCID 0000-0002-7507-7411
Seung-Yeon LeeCollege of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Beom-Ki JoCollege of Pharmacy, Seoul National University, Seoul, Republic of Korea.ORCID 0009-0009-6097-6754
Ji-Young OhCollege of Pharmacy, Seoul National University, Seoul, Republic of Korea.ORCID 0000-0002-4804-7604
Eun-Ji KwonCollege of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Keun-Tae KimCollege of Pharmacy, Seoul National University, Seoul, Republic of Korea.ORCID 0000-0002-1610-3720
Anish Ashok AdpaikarDivision in Anatomy and Developmental Biology, Department of Oral Biology, Taste Research Center, Oral Science Research Center, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.ORCID 0000-0001-6018-0427
Eun-Jung KimDivision in Anatomy and Developmental Biology, Department of Oral Biology, Taste Research Center, Oral Science Research Center, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.ORCID 0000-0002-9515-7590
Han-Sung JungDivision in Anatomy and Developmental Biology, Department of Oral Biology, Taste Research Center, Oral Science Research Center, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.ORCID 0000-0003-2795-531X
Hwa-Ryeon KimDepartment of Biochemistry, Yonsei University, Seoul, Korea.ORCID 0000-0001-9418-7061
Jae-Seok RoeDepartment of Biochemistry, Yonsei University, Seoul, Korea.
Chang Pyo HongTheragen Bio Co., Ltd, Seongnam 13488, Republic of Korea.ORCID 0000-0001-5030-1248
Jong Kyoung KimDepartment of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.ORCID 0000-0002-0257-0547
Bon-Kyoung KooCenter for Genome Engineering, Institute for Basic Science, 55, Expo-ro, Yuseong-gu, Daejeon 34126, Republic of Korea.ORCID 0000-0002-4134-8033
Hyuk-Jin ChaCollege of Pharmacy, Seoul National University, Seoul, Republic of Korea.ORCID 0000-0001-9277-2662
Seoul National University · KRYonsei University · KRPohang University of Science and Technology · KRInstitute of Molecular Biotechnology · ATTheragen · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissue regeneration after injury involves the dedifferentiation of somatic cells, a natural adaptive reprogramming that leads to the emergence of injury-responsive cells with fetal-like characteristics. However, there is no direct evidence that adaptive reprogramming involves a shared molecular mechanism with direct cellular reprogramming. Here, we induced dedifferentiation of intestinal epithelial cells using OSKM (Oct4, Sox2, Klf4, and c-Myc) in vivo. The OSKM-induced forced dedifferentiation showed similar molecular features of intestinal regeneration, including a transition from homeostatic cell types to injury-responsive-like cell types. These injury-responsive-like cells, sharing gene signatures of revival stem cells and atrophy-induced villus epithelial cells, actively assisted tissue regeneration following damage. In contrast to normal intestinal regeneration involving

Indexed as

Cellular ReprogrammingInduced Pluripotent Stem Cells

Identifiers

PMID38000027
PMCPMC10672161
OpenAlexW4388966668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.